Song, Erwei
Sun Yat-sen University · Sun Yat-sen Memorial Hospital
6 papers on CoChatORCID 0000-0002-5400-9049
Most cited papers
- Verified
CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness
Su, S., Chen, J., Yao, H., Liu, J., Yu, S., Lao, L., Wang, M., Luo, M., Xing, Y., Chen, F., et al. (2018) · Cell
Cancer Cells and MetastasisTGF-β signaling in diseases
Cited by 1,230
- Verified
Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells
Yang, M., Chen, J., Su, F., Yu, B., Su, F., Lin, L., Liu, Y., Huang, J.-D., & Song, E. (2011) · Molecular Cancer
Extracellular vesicles in diseaseImmune cells in cancer
Cited by 693
- Verified
Turning cold tumors hot: from molecular mechanisms to clinical applications
Zhang, J., Huang, D., Saw, P. E., & Song, E. (2022) · Trends in Immunology
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 534
- Verified
Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts
Song, E., Ouyang, N., Hörbelt, M., Antus, B., Wang, M., & Exton, M. S. (2000) · Cellular Immunology
Immune cells in cancerWound Healing and Treatments
Cited by 447
- Verified
Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury
Hamar, P., Song, E., Kökény, G., Chen, A., Ouyang, N., & Lieberman, J. (2004) · Proceedings of the National Academy of Sciences
Acute Kidney Injury ResearchCell death mechanisms and regulation
Cited by 250
- Verified
Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial
Liu, J., Liu, Q., Li, Y., Li, Q., Su, F., Yao, H., Su, S., Wang, Q., Jin, L., Wang, Y., et al. (2020) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersBreast Cancer Treatment Studies
Cited by 183
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free